Literature DB >> 18205324

O2 binding to human serum albumin incorporating iron porphyrin with a covalently linked methyl-L-histidine isomer.

Akito Nakagawa1, Teruyuki Komatsu, Makoto Iizuka, Eishun Tsuchida.   

Abstract

We describe the significant difference in the O2 binding affinities of human serum albumin (HSA) incorporating 5,10,15,20-tetrakis{alpha,alpha,alpha,alpha- o-(1'-methylcyclohexanamido)phenyl}porphinatoiron(II) with a covalently linked 1-methyl-L-histidine or 3-methyl-L-histidine [HSA-FeP(1-MHis), HSA-FeP(3-MHis)]. The HSA-FeP(3-MHis) showed an extraordinarily high O2 binding affinity ( P1/2 = 0.2 Torr, 25 degrees C, pH 7.4), which is close to those of relaxed-state hemoglobin and myoglobin. However, replacement of the 3-methyl-L-histidine moiety in FeP(3-MHis) by 1-methyl-L-histidine caused a 35-fold reduction in O2 affinity; the P 1/2 value of HSA-FeP(1-MHis) (22 Torr, 37 degrees C, pH 7.4) is almost identical to that of human red blood cells. Results of kinetic studies indicate that the low O2 binding affinity of FeP(1-MHis) is predominantly manifested in the high O2 dissociation rate constant. In a toluene solution, an identical relationship in the O2 binding property was similarly observed for FeP(1-MHis) and FeP(3-MHis). The axial Fe-N(1-MHis) coordination might be restrained by steric interaction between the 4-methylene group of the histidine and the porphyrin plane.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18205324     DOI: 10.1021/bc700400n

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  2 in total

1.  Degradation of Human Serum Albumin by Infrared Free Electron Laser Enhanced by Inclusion of a Salen-Type Schiff Base Zn (II) Complex.

Authors:  Yuika Onami; Takayasu Kawasaki; Hiroki Aizawa; Tomoyuki Haraguchi; Takashiro Akitsu; Koichi Tsukiyama; Mauricio A Palafox
Journal:  Int J Mol Sci       Date:  2020-01-29       Impact factor: 5.923

Review 2.  Current perspectives of artificial oxygen carriers as red blood cell substitutes: a review of old to cutting-edge technologies using in vitro and in vivo assessments.

Authors:  Nijaya Mohanto; Young-Joon Park; Jun-Pil Jee
Journal:  J Pharm Investig       Date:  2022-08-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.